Generic drugs: the stalling game.
Sweetheart deals and patent extensions keep lower-cost generic drugs from consumers.
D017277:Drug Approval / Q000191:economics / Q000331:legislation & jurisprudence*; D016527:Drug Costs / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence; D016568:Drugs, Generic / Q000191:economics / Q000600:supply & distribution; D019981:Health Care Sector / Q000331:legislation & jurisprudence; D006801:Humans; D007880:Legislation, Drug / Q000191:economics; D013997:Time Factors; D014481:United States; D014485:United States Federal Trade Commission / Q000331:legislation & jurisprudence; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence
D016568:Drugs, Generic